Back to GetFilings.com



Table of Contents

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

[X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2002

Commission file number 000-49602

SYNAPTICS INCORPORATED

(Exact name of Registrant as specified in its charter)
     
Delaware   77-0118518
(State or other jurisdiction   (I.R.S. Employer
of incorporation or organization)   Identification No.)

2381 Bering Drive
San Jose, California 95131

(Address of principal executive offices)
(Zip code)

(408) 434-0110
(Registrant’s telephone number, including area code)

Check whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes   x   No   o

Number of shares of Common Stock outstanding at November 4, 2002: 23,363,381

 


TABLE OF CONTENTS

PART 1 — FINANCIAL INFORMATION
ITEM 1. FINANCIAL STATEMENTS
CONDENSED CONSOLIDATED BALANCE SHEETS
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOW
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
ITEM 4. CONTROLS AND PROCEDURES
PART II — OTHER INFORMATION
ITEM 5. OTHER INFORMATION
ITEM 6. EXHIBITS AND REPORTS ON FORM 8-K
SIGNATURES
CERTIFICATIONS
Exhibits Index
EX-99.1
EX-99.2


Table of Contents

SYNAPTICS INCORPORATED
QUARTERLY REPORT ON FORM 10-Q
FOR THE QUARTER ENDED SEPTEMBER 30, 2002

TABLE OF CONTENTS

               
          Page
         
 
Part I. Financial Information
       
   
Item 1. Financial Statements:
       
     
Condensed Consolidated Balance Sheets-
September 30, 2002 and June 30, 2002 (Unaudited)
    3  
     
Condensed Consolidated Statements of Operations-
Three Months Ended September 30, 2002 and 2001 (Unaudited)
    4  
     
Condensed Consolidated Statements of Cash Flows-
Three Months Ended September 30, 2002 and 2001 (Unaudited)
    5  
     
Notes to Condensed Consolidated Financial Statements (Unaudited)
    6  
   
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
    10  
   
Item 3. Quantitative and Qualitative Disclosures About Market Risk
    15  
   
Item 4. Controls and Procedures
    15  
 
Part II. Other Information
       
   
Item 5. Other Information
    15  
   
Item 6. Exhibits and Reports on Form 8-K
    15  
 
Signatures
      16  
 
Certifications
      17  

 


Table of Contents

PART 1 — FINANCIAL INFORMATION

ITEM 1.   FINANCIAL STATEMENTS

SYNAPTICS INCORPORATED
CONDENSED CONSOLIDATED BALANCE SHEETS

(in thousands)

                         
            September 30,   June 30,
            2002   2002 (1)
           
 
            (unaudited)        
       
ASSETS
               
Current assets:
               
 
Cash and cash equivalents
  $ 35,163     $ 45,491  
 
Short-term investments
    29,197       19,689  
 
Accounts receivable, net of allowances of $210 and $200 at September 30, 2002 and June 30, 2002, respectively
    15,610       13,242  
 
Inventories
    6,398       5,867  
 
Prepaid expenses and other current assets
    3,495       2,964  
 
   
     
 
 
Total current assets
    89,863       87,253  
Property and equipment, net
    2,005       2,043  
Goodwill
    765       765  
Other assets
    310       320  
 
   
     
 
Total assets
  $ 92,943     $ 90,381  
 
   
     
 
     
LIABILITIES AND STOCKHOLDERS’ EQUITY
               
Current liabilities:
               
 
Accounts payable
  $ 6,096     $ 5,867  
 
Accrued compensation
    2,232       2,161  
 
Accrued warranty
    1,002       1,002  
 
Income taxes payable
    2,700       2,646  
 
Other accrued liabilities
    2,129       1,814  
 
Capital leases and equipment financing obligations
    351       445  
 
   
     
 
 
Total current liabilities
    14,510       13,935  
Capital leases and equipment financing obligations, net of current portion
    164       259  
Note payable to a related party
    1,500       1,500  
Other liabilities
    702       684  
Commitments and contingencies
               
Stockholders’ equity:
               
 
Common stock
    23       23  
 
Additional paid-in capital
    75,657       75,013  
 
Deferred stock compensation
    (975 )     (1,085 )
 
Notes receivable from stockholders
    (768 )     (876 )
 
Retained earnings
    2,065       865  
 
Accumulated other comprehensive income
    65       63  
 
   
     
 
 
Total stockholders’ equity
    76,067       74,003  
 
   
     
 
Total liabilities and stockholders’ equity
  $ 92,943     $ 90,381  
 
   
     
 


(1)   Derived from our audited financial statements as of June 30, 2002, included in our Form 10-K filed with the Securities and Exchange Commission.

See notes to condensed consolidated financial statements.

3


Table of Contents

SYNAPTICS INCORPORATED
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(in thousands, except per share data)
(unaudited)

                   
      Three Months Ended
      September 30,
     
      2002   2001
     
 
Net revenue
  $ 22,177     $ 23,569  
Cost of revenue (1)
    12,443       14,607  
 
   
     
 
 
Gross margin
    9,734       8,962  
Operating expenses:
               
 
Research and development (1)
    5,323       3,691  
 
Selling, general, and administrative (1)
    2,604       2,674  
 
Amortization of other acquired intangible assets
    30       13  
 
Amortization of deferred stock compensation
    110       121  
 
   
     
 
 
Total operating expenses
    8,067       6,499  
 
   
     
 
Operating income
    1,667       2,463  
Interest income
    277       33  
Interest expense
    (39 )     (64 )
 
   
     
 
Income before income taxes
    1,905       2,432  
Provision for income taxes
    705       845  
 
   
     
 
 
Net income
  $ 1,200     $ 1,587  
 
   
     
 
Net income per share:
               
 
Basic
  $ 0.05     $ 0.24  
 
   
     
 
 
Diluted
  $ 0.05     $ 0.08  
 
   
     
 
Shares used in computing net income per share:
               
 
Basic
    23,260       6,623  
 
   
     
 
 
Diluted
    24,840       20,362  
 
   
     
 


(1)   Cost of revenue excludes $7,000 and $7,000 of amortization of deferred stock compensation for the three months ended September 30, 2002 and 2001, respectively. Research and development expense excludes $39,000 and $49,000 of amortization of deferred stock compensation for the three months ended September 30, 2002 and 2001, respectively. Selling, general, and administrative expenses exclude $64,000 and $65,000 of amortization of deferred stock compensation for the three months ended September 30, 2002 and 2001, respectively. These amounts have been aggregated and reflected as “Amortization of deferred stock compensation.”

See notes to condensed consolidated financial statements.

4


Table of Contents

SYNAPTICS INCORPORATED
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOW

(in thousands)
(unaudited)

                     
        Three Months Ended
        September 30,
       
        2002   2001
       
 
Operating activities
               
Net income
  $ 1,200     $ 1,587  
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
               
 
Depreciation and amortization of property and equipment
    338       291  
 
Amortization of other acquired intangible assets
    30       13  
 
Amortization of deferred stock compensation
    110       121  
 
Changes in operating assets and liabilities:
               
   
Accounts receivable
    (2,368 )     (176 )
   
Inventories
    (531 )     1,869  
   
Prepaid expenses and other current assets
    (531 )     27  
   
Other assets
    (20 )     (385 )
   
Accounts payable
    229       (1,646 )
   
Accrued compensation
    71       (97 )
   
Other accrued liabilities and income taxes payable
    369       397  
   
Other liabilities
    18       21  
 
   
     
 
Net cash provided by (used in) operating activities
    (1,085 )     2,022  
Investing activities
               
Purchases of short-term investments
    (11,736 )      
Proceeds from sales and maturities of short-term investments
    2,230        
Purchase of property and equipment
    (300 )     (277 )
 
   
     
 
Net cash used in investing activities
    (9,806 )     (277 )
Financing activities
               
Payments on capital leases and equipment financing obligations
    (189 )     (146 )
Common stock issued under ESPP and stock option plans
    644       110  
Repayment of notes receivable from stockholders
    108        
 
   
     
 
Net cash provided by (used in) financing activities
    563       (36 )
 
   
     
 
Increase (decrease) in cash and cash equivalents
    (10,328 )     1,709  
Cash and cash equivalents at beginning of period
    45,491       3,766  
 
   
     
 
Cash and cash equivalents at end of period
    35,163     $ 5,475  
 
   
     
 
Supplemental disclosures of cash flow information
               
Cash paid for interest
    10       35  
Cash paid for taxes
    651       375  

See notes to condensed consolidated financial statements.

5


Table of Contents

SYNAPTICS INCORPORATED
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(unaudited)

1.   Basis of Presentation

         The accompanying unaudited condensed consolidated financial statements have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission and generally accepted accounting principles. However, certain information or footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles have been condensed, or omitted, pursuant to such rules and regulations. In our opinion, the statements include all adjustments (which are of a normal and recurring nature) necessary for the fair presentation of the results of the interim periods presented. The results of operations for the interim periods are not necessarily indicative of the operating results for the full fiscal year or any future period. These financial statements should be read in conjunction with the audited consolidated financial statements and related notes included in our annual report on Form 10-K for the year ended June 30, 2002.

         The consolidated financial statements include our financial statements and our wholly owned subsidiaries. All significant intercompany balances and transactions have been eliminated upon consolidation.

         Our fiscal year ends on the last Saturday in June. For ease of presentation, the accompanying financial statements have been shown as ending on June 30 and calendar quarter ends for all annual, interim, and quarterly financial statement captions.

2.   Net Income Per Share

         Basic net income per share amounts have been computed using the weighted-average number of shares of common stock outstanding during each period, less shares subject to repurchase. Diluted net income per share amounts also include the effect of potentially dilutive securities, including stock options, warrants, and convertible preferred stock, when dilutive.

         The following table presents the computation of basic and diluted net income per share (in thousands, except per share amounts):

                     
        Three Months Ended
        September 30,
       
        2002   2001
       
 
Numerator for basic and diluted net income per share:
               
 
Net income
  $ 1,200     $ 1,587  
 
   
     
 
Denominator for basic net income per share:
               
 
Weighted average common shares outstanding
    23,260       6,647  
 
Less: Weighted average shares subject to repurchase
          (24 )
 
   
     
 
Denominator for basic net income per share
    23,260       6,623  
 
   
     
 
Denominator for diluted net income per share:
               
 
Shares used above, basic
    23,260       6,623  
 
Dilutive stock options
    1,580       2,605  
 
Dilutive warrants
          23  
 
Dilutive preferred stock
          11,074  
 
Dilutive contingent shares
          37  
 
   
     
 
Denominator for diluted net income per share
    24,840       20,362  
 
   
     
 
Net income per share:
               
   
Basic
  $ 0.05     $ 0.24  
 
   
     
 
   
Diluted
  $ 0.05     $ 0.08  
 
   
     
 

6


Table of Contents

3.   Cash Equivalents and Short-term Investments

         Highly liquid debt securities with insignificant interest rate risk and original maturities of three months or less are classified as cash equivalents. Debt securities with maturities greater than three months are considered available-for-sale and are classified as short-term investments. Our policy is to ensure the safety and preservation of our invested funds by investing in high credit-quality financial instruments.

         All of our short-term investments were classified as available-for-sale as of the balance sheet dates presented and, accordingly, are reported at fair value with unrealized gains and losses recorded as a component of accumulated other comprehensive income in stockholders’ equity.

         As of September 30, 2002, cash, cash equivalents, and short-term investments consisted of the following (in thousands):

                                   
              Gross   Gross        
      Amortized   Unrealized   Unrealized   Fair
      Cost   Gains   Losses   Value
     
 
 
 
Cash and cash equivalents:
                               
 
Cash
  $ 3,255     $     $     $ 3,255  
 
Certificate of deposit
    24                   24  
 
Money market
    16,907                   16,907  
 
Municipal securities
    14,977                   14,977  
 
 
   
     
     
     
 
 
  $ 35,163     $     $     $ 35,163  
 
 
   
     
     
     
 
Short-term investments:
                               
 
Municipal securities
  $ 29,132     $ 65     $     $ 29,197  
 
 
   
     
     
     
 

4.   Comprehensive Income

         Comprehensive income includes all changes in stockholders’ equity during a period except those resulting from investments by owners and distributions to owners. Other comprehensive income comprises unrealized gains and losses on available-for-sale securities. Total comprehensive income for the three months ended September 30, 2002 and 2001 was $1,202,000 and $1,587,000, respectively. Accumulated other comprehensive income amounted to $65,000 and $0 as of September 30, 3002 and 2001, respectively. For the three months ended September 30, 2002 and 2001 the change in unrealized gain on marketable equity securities was $2,000 and $0, respectively.

5.   Goodwill and Other Acquired Intangible Assets

         Goodwill represents the excess purchase price of net tangible and intangible assets acquired in business combinations over their estimated fair value. Other acquired intangible assets primarily represent core technology and patent rights. In June 2001, the Financial Accounting Standards Board issued Statement of Financial Accounting Standards No. 141, Business Combinations, and No. 142, Goodwill and Other Intangible Assets (“SFAS 141” and “SFAS 142”, respectively). Adoption of SFAS 141 on July 1, 2001, did not have any impact on our financial position or historical results of operations. However, certain intangible assets that did not meet the new criteria for recognition as a separate class of intangible assets have been reclassified as part of goodwill for all periods presented.

         SFAS 142 supersedes APB Opinion No. 17, Intangible Assets, and requires goodwill and other intangible assets that have an indefinite useful life to no longer be amortized; however, these assets must be reviewed at least annually for impairment. We had previously amortized goodwill over its estimated useful life of three years; however, pursuant to the adoption of SFAS 142 on July 1, 2001, the goodwill is no longer amortized. We continue to amortize separately identifiable intangible assets with finite useful lives over periods ranging from two to three years and the adoption of SFAS 142 had no impact on such identifiable intangible assets. In our opinion, no material impairment existed at September 30, 2002.

7


Table of Contents

         Other acquired intangible assets consisted of the following (in thousands):

                   
      September 30,   June 30,